PGN 9856

ocular hypotensive agent

Also Known As:

2-(3-(3',4-difluoro-(1,1'-biphenyl)-3-carboxamido)phenoxy)acetic acid

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Miosis 10/01/2020 - "JV-GL1 and its free acid enzymatic hydrolysis product PGN 9856, over a 0.01%-0.1% dose range, reduced IOP to ≤10 mm Hg. JV-GL1 and PGN 9856 produced no miosis but a similar degree of ocular surface hyperemia to bimatoprost. "
2.	Hyperemia 10/01/2020 - "JV-GL1 and its free acid enzymatic hydrolysis product PGN 9856, over a 0.01%-0.1% dose range, reduced IOP to ≤10 mm Hg. JV-GL1 and PGN 9856 produced no miosis but a similar degree of ocular surface hyperemia to bimatoprost. "